Web Desc
HIV Pathogenesis
joint with HIV Vaccines: Current Challenges and Future Prospects
Organizer(s): Michael M. Lederman, Richard A. Koup and Michael H. Malim
Date: April 09 - 15, 2005
Location: Fairmont Banff Springs, Banff, AB, Canada
Summary of Meeting:
More than 20 years of basic and applied research have help to dissect the intimate relationship between HIV and its host. Since HIV targets, infects and compromises cells of the immune system, the interactions between this virus and host defenses are both especially complex and also offer key insights into mechanisms of cell biology, immune defenses and evolutionary adaptation. This Keystone symposium will focus on the mechanisms utilized by the virus for establishment of infection and propagation, protective innate and adaptive host defense mechanisms and mechanisms utilized by HIV to elude these defenses. This meeting will bring together scientists representing a number of different disciplines who have addressed these key issues. The goal of this meeting is to facilitate interdisciplinary interactions that will promote better insights into HIV disease pathogenesis.
Discounted Abstract Deadline: December 9 2004
Discounted Registration Deadline: February 10 2005
We gratefully acknowledge additional support for this conference from:
Boehringer Ingelheim (Canada) Ltd.Gilead Sciences, Inc.Office of AIDS Research, NIH
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13-AI064224-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Saturday, April 09 | 3:00PM - 7:30PM
Registration
Room: Van Horne Ballroom Foyer


Saturday, April 09 | 6:30PM - 7:30PM
Refreshments
Room: Van Horne Ballroom Foyer


Saturday, April 09 | 7:30PM - 9:30PM
Keynote Address (Joint)
Room: Van Horne Ballroom

Speaker 1 of 2
Douglas D. Richman, University of California, San Diego, USA
HIV Pathogenesis: Twenty Years of Successes and Failures

Saturday, April 09 | 7:30PM - 9:30PM
Keynote Address (Joint)
Room: Van Horne Ballroom

Speaker 2 of 2
José G. Esparza, Bill & Melinda Gates Foundation, USA
Harnessing Science and Policy to Accelerate HIV Vaccine Development

Sunday, April 10 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 1 of 6
* John P. Moore, Weill Medical College of Cornell University, USA

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 2 of 6
Ashley T. Haase, University of Minnesota, USA
The Fast Phase of Slow Lentiviral Infection

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 3 of 6
Susan A. Allen, Emory University School of Public Health, USA
Couples' HIV Counseling and Testing in basic science research and public health

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 4 of 6
Yvette van Kooyk, Vrije University Medical Center, Netherlands
Viruses Use Carbohydrates to Escape Immunity Induced by Dendritic Cells

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 5 of 6
Andrew Blauvelt, Oregon Health & Science University, USA
CCR5-Mediated HIV Infection of Langerhans Cells

Sunday, April 10 | 8:00AM - 11:00AM
Transmission
Room: Van Horne Ballroom AB

Speaker 6 of 6
Clare Jolly, University College London, UK
Short Talk: Cell to Cell Spread of HIV-1 Across a Virological Synapse

Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 7
* Carolyn Williamson, University of Cape Town, South Africa
Genetic Heterogeneity of Subtype C HIV-1 Infection in Africa


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 7
Francine McCutchan, PATH, USA
Screening for HIV-1 Dual Infection in Populations Exposed to Multiple Subtypes


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 7
Bette Tina Marie Korber, Los Alamos National Laboratory, USA
Understanding and Explaining the Limitations of HIV Evolution


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 7
James I. Mullins, University of Washington, USA
HIV Evolution in Forward and Reverse


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 7
Chunfu Yang, Centers for Disease Control, USA
Short Talk: Genetic Diversification and Recombination of HIV-1 Group M in Kinshasa, Democratic Republic of Congo


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 7
Wendy M. Blay, Seattle Biomedical Research Institute, USA
Short Talk: Convergent Patterns of Change in Potential N-Linked Glycosylation (PNG) Sites of SHIV89.6p


Sunday, April 10 | 8:00AM - 11:20AM
Viral Diversity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 7 of 7
Terri Wrin, Monogram Biosciences, USA
Short Talk: Evolution of HIV-1 Envelope and Antibody Neutralization Activity in Identical Twins and a Sibling Infected with the Same Virus


Sunday, April 10 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Sunday, April 10 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Greg J. Towers, University College London, UK

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 2 of 7
Vincent Piguet, Cardiff University, UK
Trafficking of HIV-1 to the Dendritic Cell-T cell Infectious Synapse Uses DC-SIGN and the Pathway of Tetraspanin Sorting to the Immunological Synapse

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 3 of 7
Mark E. Sharkey, Miller School of Medicine, University of Miami, USA
Stable Sequestration and Dissemination in Trans of Intracellular Virions by HIV-1 Infected Macrophages

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 4 of 7
Mojgan H. Naghavi, Centre for Research in Infectious Diseases, University College Dublin, Ireland
Overexpression of Fasciculation and Elongation Protein zeta-1 (FEZ1) Induces a Postentry Block to Retroviruses in Cultured Cells

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 5 of 7
Philippe Gallay, The Scripps Research Institute, USA
Interplay Between HIV-1 Capsid, Cyclophilin A and Primate Restriction

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 6 of 7
Thomas J. Hope, Northwestern University, USA
Cell Biology of TRIM5alpha

Sunday, April 10 | 2:30PM - 4:30PM
Workshop 1: Intracellular Interactions
Room: Van Horne Ballroom AB

Speaker 7 of 7
Eric Poeschla, University of Colorado School of Medicine, USA
Identification of the LEDGF/p75 HIV-1 Integrase-Interaction Domain and NLS Reveals NLS-Independent Chromatin Tethering

Sunday, April 10 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Thomas J. Hope, Northwestern University, USA

Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
Room: Van Horne Ballroom AB

Speaker 2 of 5
Robert W. Doms, University of Pennsylvania School of Medicine, USA
HIV Entry and its Inhibition

Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
Room: Van Horne Ballroom AB

Speaker 3 of 5
Judy Lieberman, Harvard University, USA
Use of Small Interfering RNAs to Block Transmission of HIV and Other Sexually Transmitted Diseases

Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
Room: Van Horne Ballroom AB

Speaker 4 of 5
Stuart F.J. Le Grice, NCI, National Institutes of Health, USA
Reverse Transcription – A New Look at an Old Adversary

Sunday, April 10 | 5:00PM - 7:15PM
Virus and Cells: The Way In
Room: Van Horne Ballroom AB

Speaker 5 of 5
Frederic D. Bushman, University of Pennsylvania, USA
Targeting of HIV DNA Integration to Transcription Units: Tethering via a Human Transcription Factor


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 6
* David I. Watkins, University of Miami, USA
CD8+ Responses in LTNP and Vaccinated Macaques


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 6
Eric Hunter, Emory University, USA
Env Determinants that Influence Neutralization Sensitivity - Lessons from Transmission Pairs


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 6
Georgia D. Tomaras, Duke University Medical Center, USA
Immune Escape in HIV-1 Infection


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 6
Catherine A. Blish, Stanford University School of Medicine, USA
Short Talk: Susceptibility of Recently Transmitted HIV-1 Variants to Neutralization by Autologous and Heterologous Plasma


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 6
Jesus F. Salazar-Gonzalez, University of Alabama at Birmingham, USA
Short Talk: HIV-1 Quasispecies Complexity in Acute and Early Infection


Sunday, April 10 | 5:00PM - 7:15PM
Transmission and Immune Escape
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 6
Marcus Altfeld, Heinrich-Pette-Institute, Germany
Short Talk: De-Novo Generation of HIV-1-Specific CD8+ T Cell Responses Directed Against CTL Escape Variants


Sunday, April 10 | 7:15PM - 8:15PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Sunday, April 10 | 7:30PM - 10:00PM
Poster Session 1
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 1 of 6
* Lynn Morris, National Institute for Communicable Diseases, South Africa
Neutralizing Antibody Responses to Subtype C HIV-1 Infection in Africa

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 2 of 6
John R. Mascola, NIAID, National Institutes of Health, USA
Evaluating the Neutralizing Antibody Response Elicited by DNA and Recombinant Adenoviral Vaccines

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 3 of 6
Dennis R. Burton, The Scripps Research Institute, USA
Envelope on the Surface on HIV is Heterogeneous

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 4 of 6
George M. Shaw, University of Pennsylvania, USA
Antigenic Conservation and Immunogenicity of the Co-Receptor Binding Site and Membrane-Proximal External Region (MPER) of HIV-1 and HIV-2

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 5 of 6
Bing Chen, Children's Hospital Boston, USA
Short Talk: Structure of an Unliganded Simian Immunodeficiency Virus gp120 Core

Monday, April 11 | 8:00AM - 11:00AM
Protective Immunity I: Neutralizing Antibodies (Joint)
Room: Van Horne Ballroom

Speaker 6 of 6
Ping Zhu, Florida State University, USA
Short Talk: Cryo-Electron Microscopy of Envelope Spikes on SIV Surfaces

Monday, April 11 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Monday, April 11 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 6
* Genoveffa Franchini, NCI, National Institutes of Health, USA
Testing Rational Approaches for Immune Therapy for HIV-1-Infected Individuals in the SIVmac251 Model


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 6
Thomas Lehner, Guy's, King's & St. Thomas' Hospital Medical and Dental School, UK
A Novel Therapeutic Immunization Strategy Against HIV


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 6
Kevin N. Brown, University of Pittsburgh, USA
Short Talk: Disproportionate Loss of CD11c+ Lymph Node Dendritic Cells in AIDS Associated with Failed Langerhans Cell Migration is Overridden by Injection of Mature Monocyte-Derived Dendritic Cells


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 6
Moiz Kitabwalla, Lipid Sciences, Inc., USA
Short Talk: Delipidated Retroviruses as Potential Autologous Therapeutic Vaccines—A Pilot Experiment


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 6
Jean D. Boyer, University of Pennsylvania, USA
Short Talk: Dramatic Induction of Antigen Specific Immune Responses and Effects on Viral Rebound Analyzed in a Novel Chronic SIV Infection Treatment Modely by Optimized SIV DNA Antigens + IL-12 Adjuvant Vaccine


Monday, April 11 | 2:30PM - 4:30PM
Workshop 1: Immune Reconstitution and Augmentation
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 6
Barbara K. Felber, NCI, National Institutes of Health, USA
Short Talk: Control of Viremia after Antiretroviral Treatment and Therapeutic Vaccination with Novel forms of DNA Vaccines in Chronically SIVmac251-Infected Macaque


Monday, April 11 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA

Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
Room: Van Horne Ballroom AB

Speaker 2 of 5
Jaisri R. Lingappa, University of Washington, USA
HIV-1 Capsid Assembly Intermediates: Biochemical Sites for Regulation of Anti-Viral Factors and Virus Production Kinetics

Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
Room: Van Horne Ballroom AB

Speaker 3 of 5
Ben Berkhout, University of Amsterdam, Academic Medical Center, Netherlands
HIV-1 Can Evade RNAi-Mediated Inhibition by Altering the Secondary Structure of its RNA Genome

Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
Room: Van Horne Ballroom AB

Speaker 4 of 5
Wesley I. Sundquist, University of Utah School of Medicine, USA
HIV-1 Budding

Monday, April 11 | 5:00PM - 7:00PM
Virus and Cells: The Way Out
Room: Van Horne Ballroom AB

Speaker 5 of 5
Elena Chertova, NCI, National Institutes of Health, USA
Short Talk: Proteomic and Biochemical Analysis of HIV-1 Produced from Human Monocyte-Derived Macrophages

Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 4
* Kent J. Weinhold, Duke University Medical Center, USA
Immunologic Hallmarks of Early Acute HIV-1 Infection in a Clade B Heterosexual Transmission Cohort - Insights for Vaccine Development


Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 4
Clive M. Gray, National Institute for Communicable Diseases, South Africa
CD8+ T Responses Associated with Control of HIV-1 Subtype C Infections


Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 4
Mark Connors, NIAID, National Institutes of Health, USA
Qualitative Features of an Effective HIV-Specific CD8+ T Cell Response


Monday, April 11 | 5:00PM - 7:15PM
Protective Immunity II: Cellular Responses
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 4
Bali Pulendran, Stanford University School of Medicine, USA
Modulating Vaccine Responses with Dendritic Cells and Pathogen Recognition Receptors


Monday, April 11 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Monday, April 11 | 7:30PM - 10:00PM
Poster Session 2
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 1 of 6
* Michael M. Lederman, Case Western Reserve University, USA

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 2 of 6
Julie M. Overbaugh, Fred Hutchinson Cancer Research Center, USA
Studies HIV-1 Acquisition in the Absence and Presence of Existing Infection

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 3 of 6
Mary Carrington, NCI, National Institutes of Health, USA
The Influence of HLA on HIV: Relating Allelic Effects in Disease Progression to Those in Infection

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 4 of 6
Steven G. Deeks, University of California, San Francisco, USA
Immune Activation, Viral Fitness and Disease Progression

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 5 of 6
Mark B. Feinberg, IAVI International AIDS Vaccine Initiative, USA
Lessons from Sooty Mangabeys

Tuesday, April 12 | 8:00AM - 11:15AM
Pathogenesis: Determinants of Disease Progression. Session
Sponsored in Part by Gilead Sciences, Inc.

Room: Van Horne Ballroom AB

Speaker 6 of 6
Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA
Immunology and Virology of Controlled HIV Infection

Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 6
* Stephen A. Udem, Wyeth Pharmaceuticals, USA
Next Generation pDNA and Recombinant VSV Vectored Vaccines for Immunization Against HIV


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 6
Richard T. Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute, USA
Analysis of HIV-1 Envelope Glycoproteins for Immunogen Design to Elicit Broadly Neutralizing Antibodies


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 6
Feng Gao, Duke University Medical Center, USA
Immunogenicity of Consensus Envelope Immunogens


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 6
James E. Robinson, Tulane University Health Sciences Center, USA
Probing the Neutralization Face of HIV-1 Env with Human Monoclonal Antibodies


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 6
Robert G. Whalen, Altravax, Inc., USA
Short Talk: Use of Directed Molecular Evolution to Create Novel HIV-1 Envelope Variants Capable of Inducing Broadly Neutralizing Antibody Responses in Rabbits


Tuesday, April 12 | 8:00AM - 11:00AM
Novel Immunogens and Vaccine Concepts I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 6
Dan H. Barouch, Beth Israel Deaconess Medical Center, USA
Short Talk: Antigen- and Vector-Specific Immune Responses Elicited by rAd5, rAd35, and Chimeric rAd35k5 Vaccines for HIV/SIV in Rhesus Monkeys


Tuesday, April 12 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Tuesday, April 12 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Irini Sereti, NIAID, National Institutes of Health, USA

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 7
Arnaud Moris, INSERM Université Pierre et Marie Curie (UPMC) Hôpital Pitié-Salpêtrière CNRS, France
HIV-1 Antigen Presentation by DCs: Role of DC-SIGN

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 7
Karin Loré, Karolinska Institutet, Sweden
Productively Infected Myeloid and Plasmacytoid Dendritic Cells Transfer of HIV-1 Preferentially to Antigen-Specific CD4+ T-Cells

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 7
Jean Philippe Herbeuval, National Cancer Institute, National Institutes of Health, USA
AIDS Pathogenesis: Effect of HAART on TRAIL/DR5 Mediated CD4+ T Cell Apoptosis

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 7
Scott F. Sieg, Case Western Reserve University, USA
Circulating S Phase T Cells from HIV-Infected Persons are Prone to Die, Express Low Levels of bcl-2 and are Rescued from Apoptosis by Interleukin-2

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 6 of 7
Michael R. Betts, University of Pennsylvania, USA
HIV-Infected Long-Term Nonprogressors Maintain Polyfunctional HIV Specific CD8+ T Cell Responses of Diverse Memory Phenotypes

Tuesday, April 12 | 2:30PM - 4:30PM
Workshkop 2: Immune Pathogenesis
Room: Van Horne Ballroom AB

Speaker 7 of 7
Emma L. Turnbull, Jenner Institute, University of Oxford, UK
Analysis of the Functional Cross-Reactivity and Clonality of HIV-Specific CD8+ T Cells Restricted by HLA Alleles Associated with Differing Rates of Progression to AIDS

Tuesday, April 12 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 1 of 8
* Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 2 of 8
* Richard A. Koup, NIAID, National Institutes of Health, USA

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 3 of 8
Cristian Apetrei, University of Pittsburgh, USA
Short Talk: SIVsm Derived from Naturally Infected Sooty Mangabeys Is Not Intrinsically Highly Pathogenic for Rhesus Macaques

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 4 of 8
Alfredo Garzino-Demo, University of Maryland School of Medicine, USA
Short Talk: Insights in the Mechanism of HIV Suppression by beta-Defensins

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 5 of 8
Sara R. Klucking, Emory University, USA
Short Talk: Functional Differences in Dendritic Cell Populations and Divergent Disease Outcomes in Primate Models of HIV Infection

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 6 of 8
Catherine S. Adamson, National Cancer Institute, National Institutes of Health, USA
Short Talk: Viral Resistance to PA-457, a Novel Inhibitor of HIV-1 Maturation: Insights in to the Drug Target and Mechanisms of Action

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 7 of 8
Joseph Mattapallil, Uniformed Services University of the Health Sciences, USA
Short Talk: Massive Infection and Loss of Memory CD4 T-cells in peripheral and mucosal Tissues During Acute SIV Infection

Tuesday, April 12 | 5:00PM - 7:00PM
Late Breaking Developments
Room: Van Horne Ballroom AB

Speaker 8 of 8
Alexandra Trkola, University of Zürich, Switzerland
Short Talk: Delay of HIV-1 Rebound after Cessation of Antiretroviral Therapy through Passive Administration of Human Neutralizing Antibodies

Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 3
Peter D. Kwong, NIAID, National Institutes of Health, USA
Crystallographic Approach to Vaccine Design Based on the Antigenic and Atomic Structure of Env


Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 3
Andrew J. McMichael, Oxford University, UK
A Boost for MVA


Tuesday, April 12 | 5:00PM - 7:00PM
Novel Immunogens and Vaccine Concepts II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 3
* Philip R. Johnson, Children's Hospital of Philadelphia, USA
rAAV Vectors as Novel HIV Vaccines


Tuesday, April 12 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Tuesday, April 12 | 7:30PM - 10:00PM
Poster Session 3
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 1 of 7
* Marcus Altfeld, Heinrich-Pette-Institute, Germany

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 2 of 7
Giuseppe Pantaleo, Centre Hospitalier Universitaire Vaudois, Switzerland
Functional Signatures of Protective Memory T-Cell Responses

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 3 of 7
Richard A. Koup, NIAID, National Institutes of Health, USA
CD8 and CD4 Cel Function in Viral Infection and Vaccintations

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 4 of 7
Joseph (Mike) McCune, Bill & Melinda Gates Foundation, USA
HIV-Induced Perturbations of CD8+ T Cell Maturation


Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 5 of 7
Annika C. Karlsson, Karolinska Institutet, Sweden
Short Talk: Diversity of Epitope and Cytokine Profiles at Different Stages of HIV-1 Infection

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 6 of 7
Sylvie Le Gall, Massachusetts General Hospital, Harvard Medical School, USA
Short Talk: Contribution of Antigen Processing to the Immunodominance of an HLA-A3-Restricted HIV Epitope

Wednesday, April 13 | 8:00AM - 11:00AM
CD8 Cell Function and Dysfunction (Joint)
Room: Van Horne Ballroom

Speaker 7 of 7
Astrid K.N. Iversen, Weatherall Institute of Molecular Medicine, UK
Short Talk: The Effect of Common Amino Acid Mutations in Overlapping HIV-1 p17 Gag CTL Epitopes on HLA Binding and Cytotoxic T-Cell Responses

Wednesday, April 13 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Wednesday, April 13 | 11:00AM - 1:00PM
Poster Setup
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 1:00PM - 10:00PM
Poster Viewing
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 5
* Jiri Mestecky, University of Alabama at Birmingham, USA
Mucosal Immune Responses to HIV in the Genital Tract of Infected, Highly Exposed Sero-negative, or Immunized Individuals


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 5
Robert W. Coombs, University of Washington, USA
Mucosal Shedding of HIV-1: Potential for Interference by Immune Responses


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 5
Ronald S. Veazey, Tulane National Primate Research Center, USA
Mucosal Cellular Responses in Nonhuman Primate Models of SIV


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 5
Igor M. Belyakov, National Cancer Institute, National Institutes of Health, USA
Short Talk: Mucosal Prime-Boost AIDS Vaccine Induces High Avidity CD8+ CTL Response and Delays Viremia After Intrarectal Infection of Macaques


Wednesday, April 13 | 2:30PM - 4:30PM
Workshop 2: Mucosal Immunity
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 5
Shehzad Iqbal, University of Toronto, Canada
Short Talk: Characterization of the Genital Mucosa of HIV Resistant Sex Workers Reveal Increased CD4+ T Cells, RANTES Levels and a Number of Potential Biomarkers by Proteomics Analysis


Wednesday, April 13 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 1 of 6
* Donald E. Mosier, The Scripps Research Institute, USA

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 2 of 6
Robert H. Silverman, Cleveland Clinic Foundation, USA
Interferon Antiviral Defenses Mediated by the 2-5A/RNase L Pathway

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 3 of 6
Aaron Weinberg, Case Western Reserve University, USA
Mucosal Antiviral beta Defensins

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 4 of 6
Greg J. Towers, University College London, UK
Restriction of Retroviral Infection by TRIM5

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 5 of 6
Michael H. Malim, King's College London, UK
APOBEC Proteins, Cytidine Deamination and Innate Resistance to HIV Infection

Wednesday, April 13 | 5:00PM - 7:30PM
Innate Host Defenses
Room: Van Horne Ballroom AB

Speaker 6 of 6
Olivier Schwartz, Institut Pasteur, France
Short Talk: APOBEC3G: An Ancestral Wide Cellular Defence Against Endogenous and Exogenous Retroviruses

Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 5
* Norman L. Letvin, Beth Israel Deaconess Medical Center, USA
Nonhuman Primate HIV Vaccine Studies: Will They be Predictive?


Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 5
Marjorie Robert-Guroff, NCI, National Institutes of Health, USA
A Role for Replication-Competent Adenovirus Recombinants in Vaccine Design


Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 5
Mauro Bendinelli, Universita di Pisa, Italy
Are there lessons that can be learned from the FIV model?


Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 5
Cristian Apetrei, University of Pittsburgh, USA
Short Talk: Molecular Epidemiology of SIVsm in Primate Centers in the United States over a 30 Year Period. Consequences for Diagnostic and Monitoring of SIVsm Infection


Wednesday, April 13 | 5:00PM - 7:15PM
Animal Models I
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 5
Salvatore T. Butera, Centers for Disease Control and Prevention, USA
Short Talk: Application of Repeated Mucosal Virus Exposures in Non-Human Primates to Evaluate Strategies to Prevent HIV-1 Transmission


Wednesday, April 13 | 7:15PM - 8:15PM
Social Hour
Room: New Brunswick, Alberta, Cascade


Wednesday, April 13 | 7:30PM - 10:00PM
Poster Session 4
Room: New Brunswick, Alberta, Cascade


Thursday, April 14 | 7:00AM - 8:00AM
Breakfast
Room: New Brunswick, Alberta, Cascade


Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 1 of 7
* Frederic D. Bushman, University of Pennsylvania, USA

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 2 of 7
Jerome A. Zack, University of California, Los Angeles, USA
Modeling HIV Latency

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 3 of 7
Gary J. Nabel, Sanofi, USA
The Gene Product Murr1 Restricts HIV-1 Replication in Resting CD4+ Lymphocytes

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 4 of 7
Jonathan Karn, Case Western Reserve University, USA
NF-kappaB and CBF-1: Specific Activators and Repressors of HIV Transcription

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 5 of 7
Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA
Cellular Factors that Influence Virus-Host Cell Interplay

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 6 of 7
Roger J. Pomerantz, Seres Therapeutics, Inc., USA
Short Talk: IL-7 Potently and Strain-Specifically Induces the Latent HIV-1 Reservoirs

Thursday, April 14 | 8:00AM - 11:15AM
Latency and Activation
Room: Van Horne Ballroom AB

Speaker 7 of 7
Nancie M. Archin, University of North Carolina at Chapel Hill, USA
Short Talk: Chromatin Deacetylation does not Precede Waning of HIV Expression

Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 6
* Anna Aldovini, Boston Children's Hospital and Harvard Medical School, USA
Control of SHIV Viremia and Disease Progression after DNA-MVA Mucosal Immunization in Macaques


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 6
James A. Hoxie, University of Pennsylvania, USA
Modulation of SIVmac Pathogenicity and Host Immune Responses by Mutations in the Envelope Transmembrane Cytoplasmic Tail


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 6
Ruth M. Ruprecht, Texas Biomedical Research Institute, USA
Harnessing the Power of Monoclonal Antibody Combinations


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 6
Vanessa M. Hirsch, NIAID, National Institutes of Health, USA
Virologic Features of Pathogenic and Natural Infection with Simian Immunodeficiency Viruses


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 6
John K. Rose, Yale University School of Medicine, USA
Short Talk: Protection Against SIVmac251 Challenge in Rhesus Macaques Vaccinated with VSV and MVA Vectors Expressing Seven SIV Genes


Thursday, April 14 | 8:00AM - 11:00AM
Animal Models II
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 6
Jeffrey D. Lifson, Leidos Biomedical Research, Inc., USA
Short Talk: Working Backwards to a Vaccine for Control of AIDS Virus Infection


Thursday, April 14 | 9:20AM - 9:40AM
Coffee Break
Room: Van Horne Ballroom Foyer


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 7
* Jorge E. Flores, PATH, USA


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 7
Qigui Yu, Canada
Expansion of HIV-1-Specific Memory CTL Responses by Dendritic Cells Infected with Human CD154 (CD40L)-Expressing ALVAC Virus: Towards the Development of Molecular Adjuvants for HIV-1 Vaccines


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 7
Richard S. Kornbluth, Multimeric Biotherapeutics, Inc., USA
Multimeric Soluble CD40 Ligand and GITR Ligand as DNA Vaccine Adjuvants


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 4 of 7
John P. Moore, Weill Medical College of Cornell University, USA
The Use of Topically Applied Imiquimod to Induce T-Helper Responses to HIV-1 Env Glycoproteins


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 5 of 7
Abdul M. Jabbar, Emory University, USA
Augmenting Immunogenicity of DNA Vaccines: Role of Plasmid-Encoded Flt-3 Ligand, as a Molecular Adjuvant in Genetic Vaccination


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 6 of 7
John R. Greenland, Harvard Medical School, USA
Beta-Amino Ester Polymers Facilitate in vivo DNA Transfection and Adjuvant Plasmid DNA Immunization


Thursday, April 14 | 2:30PM - 4:30PM
Workshop 3: Novel Adjuvants
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 7 of 7
Andreas Bråve, Karolinska Institute, Sweden
Needle Free Intradermal Delivery of a Multi-Gene/Multi-Subtype HIV-1 Vaccine with Recombinant GM-CSF


Thursday, April 14 | 4:30PM - 5:00PM
Coffee & Snacks Available
Room: Van Horne Ballroom Foyer


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
Room: Van Horne Ballroom AB

Speaker 1 of 5
* Gene M. Shearer, National Cancer Institute, National Institutes of Health, USA

Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
Room: Van Horne Ballroom AB

Speaker 2 of 5
Rafick Sekaly, Emory University, USA
Genomic Profiling of Memory T Cell Population in Healthy and HIV Patients

Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
Room: Van Horne Ballroom AB

Speaker 3 of 5
Daniel C. Douek, NIAID, National Institutes of Health, USA
T-Cell Receptor Recognition Motifs and Immune Escape in Acute SIV Infection

Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
Room: Van Horne Ballroom AB

Speaker 4 of 5
Fatema A. Legrand, University of California, San Francisco, USA
Short Talk: Divergent Immune Responses in HIV-1 Vertically
Infected Monozygotic Twins


Thursday, April 14 | 5:00PM - 6:45PM
Immune Defense and Pathogenesis
Room: Van Horne Ballroom AB

Speaker 5 of 5
Guillaume B.E. Stewart-Jones, National Institutes of Health, USA
Short Talk: Crystal Structures of HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLA Motifs

Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 1 of 3
* Barney S. Graham, NIAID, National Institutes of Health, USA
Update on VRC Clinical Trials of Multi-Clade DNA and rAd5 Vaccines


Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 2 of 3
John W. Shiver, Sanofi Pasteur, USA
Development of an HIV-1 Vaccine Based on Replication-Defective Adenovirus Vectors


Thursday, April 14 | 5:00PM - 7:00PM
Clinical HIV Vaccine Trials
This session is from HIV Vaccines
Room: Van Horne Ballroom C

Speaker 3 of 3
Jorge E. Flores, PATH, USA
The HIV-1 Vaccine Pipeline and Global Expansion of Clinical Trials


Thursday, April 14 | 6:45PM - 7:00PM
Closing Remarks
Room: Van Horne Ballroom AB

Speaker 1 of 1
Michael M. Lederman, Case Western Reserve University, USA

Thursday, April 14 | 7:00PM - 8:00PM
Social Hour
Room: New Brunswick, Alberta, Riverview


Thursday, April 14 | 8:00PM - 11:00PM
Entertainment
Room: New Brunswick, Alberta, Riverview


Thursday, April 14 | 8:00PM - 11:00PM
Cash Bar
Room: New Brunswick, Alberta, Riverview


Friday, April 15 | 10:26AM - 10:26AM
Departure


*Session Chair.